By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR CHLOROQUINE HYDROCHLORIDE
» See Plans and Pricing
All Clinical Trials for Chloroquine Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00074841 | Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India | Completed | Pfizer | Phase 2/Phase 3 | 2003-09-01 | This primary objective of this study is to assess whether the combination of Azithromycin with chloroquine is non-inferior to the combination of sulfadoxine-pyrimethamine plus chloroquine, when used to treat uncomplicated cases of malaria due to Plasmodium falciparum in adults in India. |
| NCT00082563 | Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum | Terminated | Pfizer | Phase 2 | 2004-08-01 | The purpose of this study is to determine if Azithromycin in combination with chloroquine is superior to chloroquine alone in eradicating P. falciparum asexual parasitemia in asymptomatic, semi-immune adults in Western Kenya. |
| NCT00082576 | Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa | Completed | Pfizer | Phase 2/Phase 3 | 2004-06-01 | The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to mefloquine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum. |
| NCT00084227 | Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America | Completed | Pfizer | Phase 2/Phase 3 | 2004-07-01 | The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to atovaquone-proguanil for the treatment of symptomatic, uncomplicated malaria due to P. falciparum. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Chloroquine Hydrochloride
Condition Name
Clinical Trial Locations for Chloroquine Hydrochloride
Trials by Country
Clinical Trial Progress for Chloroquine Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Chloroquine Hydrochloride
Sponsor Name
| Sponsor Name for Chloroquine Hydrochloride | |
| Sponsor | Trials |
| University of Oxford | 19 |
| London School of Hygiene and Tropical Medicine | 15 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 13 |
| [disabled in preview] | 13 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
